- Home
- NTRP vs ATHA Comparison
NTRP vs ATHA Comparison
Compare NTRP & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRP
- ATHA
- Stock Information
- Founded
- NTRP 1985
- ATHA 2011
- Country
- NTRP United States
- ATHA United States
- Employees
- NTRP N/A
- ATHA N/A
- Industry
- NTRP
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- NTRP
- ATHA Health Care
- Exchange
- NTRP NYSE
- ATHA Nasdaq
- Market Cap
- NTRP 24.8M
- ATHA 21.0M
- IPO Year
- NTRP N/A
- ATHA 2020
- Fundamental
- Price
- NTRP $2.36
- ATHA $0.29
- Analyst Decision
- NTRP Hold
- ATHA Buy
- Analyst Count
- NTRP 1
- ATHA 4
- Target Price
- NTRP $5.00
- ATHA $11.25
- AVG Volume (30 Days)
- NTRP 53.5K
- ATHA 217.3K
- Earning Date
- NTRP 05-06-2025
- ATHA 05-14-2025
- Dividend Yield
- NTRP N/A
- ATHA N/A
- EPS Growth
- NTRP N/A
- ATHA N/A
- EPS
- NTRP N/A
- ATHA N/A
- Revenue
- NTRP $623,664.00
- ATHA N/A
- Revenue This Year
- NTRP $354.28
- ATHA N/A
- Revenue Next Year
- NTRP $536.37
- ATHA N/A
- P/E Ratio
- NTRP N/A
- ATHA N/A
- Revenue Growth
- NTRP 186.93
- ATHA N/A
- 52 Week Low
- NTRP $1.39
- ATHA $0.22
- 52 Week High
- NTRP $8.50
- ATHA $3.67
- Technical
- Relative Strength Index (RSI)
- NTRP 31.39
- ATHA 49.02
- Support Level
- NTRP $2.41
- ATHA $0.22
- Resistance Level
- NTRP $3.28
- ATHA $0.30
- Average True Range (ATR)
- NTRP 0.77
- ATHA 0.03
- MACD
- NTRP -0.24
- ATHA 0.01
- Stochastic Oscillator
- NTRP 8.20
- ATHA 79.22
About NTRP NEXTTRIP INC
NextTrip Inc is a technology-driven platform delivering travel booking and travel media solutions. It provides individual and group travelers with vacations to popular and sought-after destinations in Mexico, the Caribbean, and across the world. NextTrip Media platform - Travel Magazine offers a social media platform for viewers to explore, educate, and share with friends their bucket list travel. The company is also launching an end-to-end content ecosystem that uses AI-assisted travel planning capturing advertising, building brand awareness, rewarding loyalty, and driving bookings.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.